Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Fructus Liquidambaris Contributes to the Chemotaxis of Eosinophils and Secretion of Cytokines in A549 Human Epithelial Cells

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2008, v.29 no.4, pp.146-160





  • Downloaded
  • Viewed

Abstract

Objectives: The present study was designated to evaluate the direct effects of Fructus Liquidambaris on suppression of eosinophil activity and on suppression of chemokines such as eotaxin, IL-8, ICAM-1, and VCAM-1, in vitro. Methods: A549 cells were stimulated with TNF-α (100 ng/ml), IL-4 (100 ng/ml) or IL-1β(10 ng/ml) to induce chemokines and adhesion molecules involved in eosinophil chemotaxis. Then after treatment of Fructus Liquidambaris, inhibition effect assay such as ELISA, real-time RT-PCR, and chemotaxis assay was performed. Results: Eotaxin level was suppressed in both protein secretion and mRNA expression. Eosinophil recruitment to lung epithelial cells was also reduced by Fructus Liquidambaris, implying the role of eotaxin in eosinophil recruitment. In addition, expression of IL-8 was also suppressed by Fructus Liquidambaris (p<0.05). However, expression of adhesion molecules (ICAM-1, VCAM-1) related to eosinophil was not affected. The eosinophil migration was inhibited at high concentration of Fructus Liquidambaris (p<0.05). Conclusion: These results suggest that Fructus Liquidambaris may regulate a common signaling pathway of eotaxin and IL-8. FS might be of therapeutic value in diseases such as asthma.

keywords
Fructus Liquidambaris, eosinophil, eotaxin, asthma, chemokine.


Reference

1

1. 전국한의과대학 폐계내과학교실. 동의폐계내과학., 서울: 도서출판국진; 2004, p.321-2, 329-31.

2

2. Darryl Adamko, Solomon Olawole Odemuyiwa, Redwan Moqbel. The eosinophil as a therapeutic target in asthma: beginning of the end, or end of the beginning. Current Opinion in Pharmac- ology. 2003;3:227-32.

3

3. 대한 천식 및 알레르기 학회. 천식과 알레르기. 서울: 군자출판사; 2002, p.59-62, 237-56.

4

4. Rothenberg ME. Eosinophilia. N Engl J Med. 1998;338(22):1592-600.

5

5. Kay AB. The role of eosinophils in the pathoge- nesis of asthma. Trends Mol Med. 2005 Apr; 11(4):142-52.

6

6. Pilewski JM, Albelda SM. Cell adhesion molec- ules in asthma: homing, activation, and airway remodeling. Am J Respir Cell Mol Biol. 1995 Jan;12(1):1-3.

7

7. 이양근. 알레르기 질환에서의 유착분자. 중앙의학. 1995;60(7):568-72.

8

8. Pope SM, Zimmermann N, Stringer KF, Karow ML, Rothenberg ME. The eotaxin chemokines and CCR3 are fundamental regulators of allergen- induced pulmonary eosinophilia. J Immunol. 2005;175(8):5341-50.

9

9. Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepada EA, Allakhverdi Z, Ghaffar O, Rothenberg MD et al.. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Imm- unol. 1997;159(9):4593-601.

10

10. 정광진, 정희재, 정승기, 이형구. 瀉白散과 瀉白散加沙蔘이 人間 氣管支上皮細胞의 IL-6, IL-8 및 GM-CSF 發顯에 미치는 影響. 大韓韓方內科學會誌. 2002;23(1):15-24.

11

11. 박상현, 정희재, 정승기, 이형구. 麻杏甘石湯과 桔梗이 인간기관지 상피세포의 Cytokine에 미치는 영향. 慶熙醫學. 2001;17(2):230-41.

12

12. 김동일, 정희재, 정승기, 이형구. 五味子, 黃連이 BEAS-2B 인간 기관지상피세포의 IL-6, IL-16, GM-CSF mRNA level에 미치는 영향. 慶熙醫學. 2001;17(2):199-213.

13

13. 정해준, 정희재, 정승기, 이형구. 麥門冬淸肺飮과 麥門冬이 인간 기관지상피세포의 IL-6, IL-16, GM-CSF mRNA level에 미치는 영향. 大韓韓醫學會誌. 2002;23(1):11-23.

14

14. 정진용, 정희재, 정승기, 이형구. 小靑龍湯과 小靑龍湯加沙蔘이 BEAS-2B 人間 氣管支上皮細胞의 IL-6, IL-8 및 GM-CSF mRNA level에 미치는 影響. 大韓韓醫學會誌. 2003;24(1): 74-83.

15

15. 정희재, 박성규, 정승기, 이형구. 金銀花와 白芍藥이 BEAS-2B 인간 기관지상피세포의 Cytokines mRNA level에 미치는 影響. 大韓韓醫學會誌. 2003;24(3):145-54.

16

16. 한동하, 정희재, 정승기, 이형구. 水蛭의 制法에 따른 BEAS-2B 人間 氣管支上皮細胞의 炎症誘發性 Cytokines 發顯에 미치는 影響. 大韓韓方內科學會誌. 2004;25(4-2):260-73.

17

17. 심대식. 乾漆이 인간기관지상피세포 cytokine 분비와 호산구 chemotaxis에 미치는 영향. 경희대학교 박사학위논문. 2006.

18

18. 최현. 五味子가 인간기관지상피세포 cytokine 분비와 호산구 chemotaxis에 미치는 영향, 경희대학교 박사학위논문. 2007.

19

19. 동양의학대사전편찬위원회. 동양의학대사전. 서울: 경희대학교출판국; 1999, p379-80.

20

20. 陳小川, 王浦林, 王晶晶. 路路通配甲壳素鎭痛與抗炎作用的硏究及治療類風濕性關節炎的治療觀察. 四川中醫. 2003;21(6):15.

21

21. 刘婷, 孙玉茹, 秦彩玲, 武桂兰, 張車, 李車成, 李兰芳 et al. 路路通酸的抗炎鎭痛作用. 中國實驗方劑學雜誌. 2006;12(12):45-7.

22

22. 이상인, 안덕균, 신민교, 노승현, 이영종, 김완희. 한약임상응용. 서울: 전통문화연구소; 1986, p296-7.

23

23. 이형구, 정승기. 동의폐계내과학, 서울: 아트동방; 1999, p.162-202.

24

24. 서울대학교의과대학편저. 호흡기학. 서울: 서울대학교 출판부; 1988, p.167-73.

25

25. 정희재, 정승기, 이형구. 臨床肺系內科學. 서울: 한문화사; 2003, p.138-40.

26

26. 안효섭. 홍창의소아과학. 서울: 대한교과서(주); 2004, p.1192-3.

27

27. Wardlaw AJ , Dunnette S, Gleich GJ , Collins JV , Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity . Am Rev Respir Dis. 1988;137:62-9.

28

28. Lam S , LeRiche J , Phillips D, Chan-Yeung M. Cellular and protein changes in bronchial lavage fluid after late asthmatic reaction in patients with red cedar asthma. J Allergy Clin Immunol. 1987; 80: 44-50.

29

29. Asky JA, Brody AR. Interleukins involved in the pathogenesis of chronic airway inflammation. Resp Immunol. 1997;142(1):39-47.

30

30. Palma Carlos AG, Palma Carlos ML, Conceicao SM, Alcinda M. Cytokines and asthma. J Invest Allergol Clin Immunol. 1997;7(5):270-3.

31

31. Rothenberg ME. Eosinophilia. N Engl J Med. 1998;338:1592-600.

32

32. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P et al. Asthma exacerba- tions and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002:360:1715-21.

33

33. 정일엽, 박춘식. 호산구와 관련된 chemokine에 대한 새로운 조명. 천식 및 알레르기. 2001;21 (2):161-72.(741)

34

34. Rothenberg ME and Hogan SP. Chemokines in Allergic Disease. Philadelphia: Lippincott Raven Publishers; 2000, p.1-15.

35

35. Wilkinson PC. Chemotaxis and Inflammation. 2nd ed. Churchill Livingston e, 1982

36

36. 이경형, 안덕균, 신민교, 김창문 외. 완역중약대사전. 서울: 정담출판사; 1997, p738-9.

37

37. Li C, Sun YR, Sun YF. Chemical composition of Fructus Liquidambaris(lulutong), Yao Xue Xue Bao. 2002 Apr;37(4):263-6.

38

38. Nagasawa H, Sakamoto S, Mori T, Wu G, Piuo H, Li Y, Li Y et al. Effects of some natural products as components of Chinese herbal medi- cines on mammary gland growth and function in mice. In Vivo. 1992 Mar-Apr;6(2):135-40.

39

39. Atasoy U, Curry SL, Lopez de Silanes I, Shyu AB, Casolaro V, Gorospe M, Stellato C. Regul- ation of eotaxin gene expression by TNF-αlpha and IL-4 through mRNA stabilization: involve- ment of the RNA-binding protein HuR. J Immunol. 2003;171(8):4369-78.

40

40. Ulfman LH, Alblas J, van Aalst CW, Zwaginga JJ, Koenderman L. Differences in Potency of CXC Chemokine Ligand 8-, CC Chemokine Ligand 11-, and C5a-Induced Modulation of Integrin Function on Human Eosinophils. J Immunol. 2005;175(9):6092-9.

41

41. Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N et al. Chemokine receptor usageby human eosinophils: the importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest. 1997;99:178-84.

42

42. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen- induced tissue eosinophilia. J Exp Med. 1997; 185(4):785-90.

43

43. Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepada EA, Allakhverdi Z, Ghaffar O et al. Increased expression of eotaxin in bronchoal- veolar lavage and airways of asthmatics contrib- utes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997;159:4593-601.

44

44. Lampinen M, Rak S, Venge P. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy. 1999;29(3):314 -22.(742)

45

45. Collins PD, Weg VB, Faccioli LH, Watson ML, Moqbel R, Williams TJ. Eosinophil accumulation in duced by human interleukin-8 in the guinea- pig in vivo. Immunology. 1993;79:312-8.

46

46. 이경기, 정희재, 이형구, 정승기. 사람 비만細胞柱에서의 케모카인에 對한 地黃平喘湯의 效果. 대한한방내과학회지. 2002;23(3):375-85.

47

47. 이형철, 정희재, 이형구, 정승기. 사람 Mast cell에서의 케모카인에 대한 白蓮治哮湯의 효과. 대한한방내과학회지. 2004;25(4-2):356-63.

48

48. Tadros T, Traber DL, Hegger JP, Herndon DN. Effects of interleukin-1alpha administration on intestinal ischemia and reperfusion injury, mucosal permeability, and bacterial translocation in burn and sepsis, Ann Surg. 2003;237:101-109.

49

49. Lebedeva T, Dustin ML, Sykulev Y. ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr Opin Immunol. 2005;17(3): 251-8.

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine